Familial Cancer

Papers
(The H4-Index of Familial Cancer is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-07-01 to 2026-07-01.)
ArticleCitations
Laboratory variation in the grading of dysplasia of duodenal adenomas in familial adenomatous polyposis patients25
Prevalence of cardiometabolic outcomes in women who underwent salpingo-oophorectomy to prevent hereditary breast and ovarian cancer: a meta-analysis25
Colonoscopy surveillance in Lynch syndrome is burdensome and frequently delayed23
Cascade genetic testing: an underutilized pathway to equitable cancer care?22
Hereditary breast and ovarian cancer genetic testing in unselected patients: example of private supplementation of public healthcare service18
Detection of a major Lynch Syndrome-causing MLH1 founder variant in a large-scale genotyped cohort17
Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review16
Hereditary acute myeloid leukemia associated with C-terminal CEBPA germline variants14
Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review13
Digital innovation for cancer risk assessment allows large-scale service redevelopment of regional cancer genetics service delivery13
Clinician perspectives on policy approaches to genetic risk disclosure in families11
0.078118085861206